2024

1. AI is a viable alternative to high throughput screening: a 318-target study

   Scientific Reports, Vol. 14, Núm. 1

2. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

   JHEP Reports, Vol. 6, Núm. 1

3. Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

   Gene Therapy, Vol. 31, Núm. 9-10, pp. 455-466

4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

   Scientific Reports

5. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

   Molecular Therapy Nucleic Acids

6. Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice

   Viruses, Vol. 16, Núm. 3

7. Dendritic Cells in Cancer Immunology and Immunotherapy

   Cancers, Vol. 16, Núm. 5

8. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

   EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131

9. Exploring current and emerging therapies for porphyrias

   Liver International, Vol. 44, Núm. 9, pp. 2174-2190

10. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

    Translational Neurodegeneration

11. Gene editing in liver diseases

    FEBS Letters

12. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut

13. MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 17, Núm. 6, pp. 887-906

14. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

    Science Advances, Vol. 10, Núm. 28

15. Multiscale and multimodal evaluation of autosomal dominant polycystic kidney disease development

    Communications Biology, Vol. 7, Núm. 1

16. Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity

    Journal of Neuroinflammation, Vol. 21, Núm. 1

17. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

18. Oxygen control in bioreactor drives high yield production of functional hiPSC-like hepatocytes for advanced liver disease modelling

    Scientific Reports, Vol. 14, Núm. 1

19. Porphyrins and the porphyrias

    Liver International

20. Profile of plasma microRNAs as a potential biomarker of Wilson’s disease

    Journal of Gastroenterology, Vol. 59, Núm. 10, pp. 921-931